Why the study?
The mechanisms for reducing asymmetric dimethylarginine (ADMA) levels to inhibit cardiovascular disease progression remain unclear, and linking ADMA to angiogenesis may help explain these multifactor mechanisms.
Design
Review
Authors
Loading...
ADMA may mark endothelial damage in CVD; hypothesis-generating for angiogenesis link, requiring prospective validation.
Key points are not available for this paper at this time.
Wieczór et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: